K193407: Contour® next GEN Blood Glucose Monitoring System (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K193407 (Contour® next GEN Blood Glucose Monitoring System, cleared 2021-12-23 for Ascensia Diabetes Care) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K193407 |
| Cleared Device Trade / Generic Name | Contour® next GEN Blood Glucose Monitoring System |
| FDA Applicant on Filing | Ascensia Diabetes Care |
| FDA 3-Letter Product Classification | Product Code NBW |
| FDA Substantial Equivalence Decision Date | 2021-12-23 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Ascensia Diabetes Care, compare peer devices under FDA Product Code NBW, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.